Authors:
HUCKLE WR
DRAG MD
ACKER WR
POWERS M
MCFALL RC
HOLDER DJ
FUJITA T
STABILITO II
KIM D
ONDEYKA DL
MANTLO NB
CHANG RSL
REILLY CF
SCHWARTZ RS
GREENLEE WJ
JOHNSON RG
Citation: Wr. Huckle et al., EFFECTS OF SUBTYPE-SELECTIVE AND BALANCED ANGIOTENSIN-II RECEPTOR ANTAGONISTS IN A PORCINE CORONARY-ARTERY MODEL OF VASCULAR RESTENOSIS, Circulation, 93(5), 1996, pp. 1009-1019
Authors:
MELLOTT MJ
RAMJIT DR
STABILITO II
HARE TR
SENDERAK ET
LYNCH JJ
GARDELL SJ
Citation: Mj. Mellott et al., VAMPIRE BAT SALIVARY PLASMINOGEN-ACTIVATOR EVOKES MINIMAL BLEEDING RELATIVE TO TISSUE-TYPE PLASMINOGEN-ACTIVATOR AS ASSESSED BY A RABBIT CUTICLE BLEEDING-TIME MODEL, Thrombosis and haemostasis, 73(3), 1995, pp. 478-483
Authors:
LYNCH JJ
COOK JJ
SITKO GR
HOLAHAN MA
RAMJIT DR
MELLOTT MJ
STRANIERI MT
STABILITO II
ZHANG GX
LYNCH RJ
MANNO PD
CHANG CTC
EGBERTSON MS
HALCZENKO W
DUGGAN ME
LASWELL WL
VASSALLO LM
SHAFER JA
ANDERSON PS
FRIEDMAN PA
HARTMAN GD
GOULD RJ
Citation: Jj. Lynch et al., NONPEPTIDE GLYCOPROTEIN IIB IIIA INHIBITORS .5. ANTITHROMBOTIC EFFECTS OF MK-0383/, The Journal of pharmacology and experimental therapeutics, 272(1), 1995, pp. 20-32
Authors:
KRAUSE SM
LYNCH JJ
STABILITO II
WOLTMANN RF
Citation: Sm. Krause et al., INTRAVENOUS ADMINISTRATION OF THE ENDOTHELIN-1 ANTAGONIST BQ-123 DOESNOT AMELIORATE MYOCARDIAL ISCHEMIC-INJURY FOLLOWING ACUTE CORONARY-ARTERY OCCLUSION IN THE DOG, Cardiovascular Research, 28(11), 1994, pp. 1672-1678
Authors:
GOULD RJ
LYNCH JJ
SCHAFFER L
SIEGL PKS
SITKO GR
RAMJIT DR
MELLOTT MJ
STABILITO II
FRIEDMAN PA
EGBERTSON M
HALCZENKO W
LASWELL WL
SMITH RL
ANDERSON PS
HARTMAN G
Citation: Rj. Gould et al., MK-0383, A NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONIST, PREVENTS THROMBOSIS IN CANINE AND PRIMATE MODELS, Thrombosis and haemostasis, 69(6), 1993, pp. 539-539
Authors:
CONNOLLY TM
HOLAHAN MA
STABILITO II
LEHMAN ED
MELLOTT MJ
LYNCH JJ
Citation: Tm. Connolly et al., THE LEECH ANTIPLATELET PROTEIN INHIBITS PLATELET-AGGREGATION BUT DOESNOT INHIBIT CYCLIC FLOW REDUCTIONS OR DELAY THE TIME TO OCCLUSION IN CANINE MODELS OF CORONARY-ARTERY THROMBOSIS, Thrombosis and haemostasis, 69(6), 1993, pp. 589-589
Authors:
REILLY CF
FUJITA T
MCFALL RC
STABILITO II
ENG WS
JOHNSON RG
Citation: Cf. Reilly et al., PHARMACOLOGICAL AND MECHANISTIC ASPECTS CONCERNING THE USE OF HEPARINAND BETA-CYCLODEXTRIN TETRADECASULFATE FOR THE TREATMENT OF VASCULAR RESTENOSIS, Drug development research, 29(2), 1993, pp. 137-147
Authors:
MELLOTT MJ
STRANIERI MT
SITKO GR
STABILITO II
LYNCH JJ
VLASUK GP
Citation: Mj. Mellott et al., ENHANCEMENT OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR-INDUCED REPERFUSION BY RECOMBINANT TICK ANTICOAGULANT PEPTIDE, A SELECTIVE FACTOR-XA INHIBITOR, IN A CANINE MODEL OF FEMORAL ARTERIAL THROMBOSIS, Fibrinolysis, 7(3), 1993, pp. 195-202
Authors:
RAMJIT DR
LYNCH JJ
SITKO GR
MELLOTT MJ
HOLAHAN MA
STABILITO II
STRANIERI MT
ZHANG GX
LYNCH RJ
MANNO PD
CHANG CTC
NUTT RF
BRADY SF
VEBER DF
ANDERSON PS
SHEBUSKI RJ
FRIEDMAN PA
GOULD RJ
Citation: Dr. Ramjit et al., ANTITHROMBOTIC EFFECTS OF MK-0852, A PLATELET FIBRINOGEN RECEPTOR ANTAGONIST, IN CANINE MODELS OF THROMBOSIS, The Journal of pharmacology and experimental therapeutics, 266(3), 1993, pp. 1501-1511